News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
55,755 Results
Type
Article (4116)
Company Profile (8)
Press Release (51629)
Multimedia
Podcasts (16)
Webinars (3)
Section
Business (16464)
Career Advice (243)
Deals (2376)
Drug Delivery (30)
Drug Development (8842)
Employer Resources (18)
FDA (1634)
Job Trends (1593)
News (27607)
Policy (2864)
Tag
2026 Best Places to Work (1)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Premier (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (413)
Accelerated approval (4)
ADA (6)
Adcomms (5)
Allergies (22)
Alliances (3532)
ALS (29)
Alzheimer's disease (149)
Antibody-drug conjugate (ADC) (98)
Approvals (1680)
Artificial intelligence (93)
ASCO (36)
Autoimmune disease (39)
Automation (5)
Bankruptcy (21)
Belgium (3)
Best Places to Work (1343)
BIO (1)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (27)
BioSpace Insights (27)
Biotechnology (4)
Bispecific (10)
Bladder cancer (22)
Brain cancer (9)
Breast cancer (105)
Cancer (834)
Cardiovascular disease (103)
Career advice (221)
Career pathing (14)
CAR-T (63)
CDC (9)
CDMO (28)
Celiac Disease (1)
Cell therapy (149)
Cervical cancer (7)
Clinical research (8050)
Collaboration (220)
Commercialization (7)
Company closure (1)
Compensation (140)
Complete response letters (5)
COVID-19 (355)
CRISPR (17)
C-suite (141)
Cystic fibrosis (12)
Data (1142)
Decentralized trials (1)
Denatured (1)
Depression (14)
Dermatology (17)
Diabetes (82)
Diagnostics (528)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (9)
Drug discovery (64)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (41)
Earnings (6098)
Editorial (6)
Employer branding (2)
Employer resources (21)
ESMO (56)
Events (7399)
Executive appointments (121)
FDA (2181)
Fragile X (2)
Friedreich's ataxia (4)
Frontotemporal dementia (3)
Funding (245)
Gene editing (40)
Generative AI (9)
Gene therapy (129)
GLP-1 (138)
Government (633)
Grass and pollen (1)
Guidances (42)
Healthcare (1886)
Hematology (24)
HIV (10)
Huntington's disease (7)
IgA nephropathy (7)
Immunology and inflammation (25)
Immuno-oncology (12)
Indications (26)
Infectious disease (391)
Inflammatory bowel disease (16)
Inflation Reduction Act (4)
Influenza (8)
Intellectual property (23)
Interviews (42)
IPO (1199)
IRA (5)
Job creations (274)
Job search strategy (172)
JPM (10)
Kidney disease (31)
Labor market (24)
Layoffs (46)
Leadership (16)
Legal (423)
Licensing (10)
Liver cancer (14)
Longevity (6)
Lung cancer (113)
Lymphoma (68)
Machine learning (10)
Management (7)
Manufacturing (126)
Marketing (2)
MASH (18)
Medical affairs (1)
Medical device (911)
Medtech (932)
Mergers & acquisitions (1281)
Metabolic disorders (173)
mRNA (33)
Multiple sclerosis (18)
NASH (1)
Netherlands (6)
Neurodegenerative disease (47)
Neuropsychiatric disorders (10)
Neuroscience (330)
Neurotech (1)
NextGen: Class of 2026 (667)
Non-profit (612)
Now hiring (17)
Obesity (74)
Opinion (58)
Ovarian cancer (25)
Pain (34)
Pancreatic cancer (75)
Parkinson's disease (34)
Partnered (6)
Patents (47)
Patient advocacy (1)
Patient recruitment (77)
Patient selection (9)
Peanut (7)
People (4796)
Peptides (4)
Pharmaceutical (1)
Pharmacy benefit managers (5)
Phase 1 (2698)
Phase 2 (3546)
Phase 3 (2605)
Pipeline (1320)
Policy (45)
Postmarket research (319)
Preclinical (660)
Press Release (4)
Prostate cancer (26)
Psychedelics (7)
Radiopharmaceuticals (23)
Rare diseases (184)
Real estate (468)
Recruiting (9)
Regenerative medicine (2)
Regulatory (2497)
Reports (6)
Research institute (345)
Resumes & cover letters (24)
Rett syndrome (2)
RNA editing (4)
RSV (4)
Schizophrenia (17)
Series A (36)
Series B (19)
Sickle cell disease (10)
Special edition (5)
Spinal muscular atrophy (27)
Sponsored (7)
Startups (318)
State (1)
Stomach cancer (5)
Substance use disorders (2)
Supply chain (13)
Switzerland (2)
Tariffs (8)
The Weekly (14)
Vaccines (154)
Venture capital (26)
Weight loss (49)
Women's health (13)
Worklife (2)
Date
Today (12)
Last 7 days (67)
Last 30 days (315)
Last 365 days (2763)
2026 (2329)
2025 (2540)
2024 (2836)
2023 (3196)
2022 (4227)
2021 (4585)
2020 (4502)
2019 (4523)
2018 (3308)
2017 (2680)
2016 (2545)
2015 (2873)
2014 (2070)
2013 (1611)
2012 (1739)
2011 (1891)
2010 (1451)
Location
Africa (96)
Alabama (7)
Alaska (2)
Arizona (73)
Arkansas (1)
Asia (3750)
Australia (502)
California (1273)
Canada (389)
China (195)
Colorado (54)
Connecticut (50)
Delaware (45)
Europe (7928)
Florida (183)
Georgia (37)
Idaho (2)
Illinois (101)
India (19)
Indiana (63)
Iowa (5)
Japan (120)
Kansas (12)
Kentucky (4)
Louisiana (9)
Maine (6)
Maryland (157)
Massachusetts (844)
Michigan (11)
Minnesota (57)
Missouri (19)
Montana (5)
Nebraska (3)
Nevada (11)
New Hampshire (4)
New Jersey (466)
New York (386)
North Carolina (202)
Northern California (799)
Ohio (41)
Oklahoma (5)
Oregon (7)
Pennsylvania (262)
Puerto Rico (2)
Rhode Island (9)
South America (90)
South Carolina (5)
Southern California (364)
Tennessee (23)
Texas (201)
United States (4584)
Utah (13)
Virginia (28)
Washington D.C. (3)
Washington State (81)
West Virginia (1)
Wisconsin (11)
Wyoming (3)
55,755 Results for "seven bridges".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Biotechs going to market alone must learn to go global
Drug developers increasingly have the option of seeking regulatory approval and commercializing a medicine themselves, rather than accepting an early exit offer. Doing so requires a worldwide strategy.
October 28, 2026
·
3 min read
·
Paul Bridges
Press Releases
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
October 23, 2026
·
7 min read
Press Releases
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
October 7, 2026
·
3 min read
Press Releases
Lupus Research Alliance Announces 2026 Translational Bridge Awards to Accelerate Promising Lupus Therapies
September 23, 2026
·
4 min read
Press Releases
Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026
October 29, 2026
·
8 min read
China
With China rising, Hong Kong builds bridge to biotech innovation
Massachusetts-based biotech accelerator LabCentral signed an agreement with Hong Kong Science and Technology Parks Corporation in June to connect founders with the U.S. ecosystem—and fuel more innovation.
August 19, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
October 18, 2026
·
5 min read
Press Releases
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
·
8 min read
Press Releases
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
·
8 min read
Press Releases
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation
September 9, 2026
·
7 min read
1 of 5,576
Next
